STAT+: Abridge inks deals with Nvidia and Lilly
Why this matters: health reporting relevant to everyday decisions and well-being.
NEW YORK — Health care artificial intelligence company Abridge on Thursday announced new deals with two trillion-dollar companies, pharma giant Eli Lilly and chipmaker Nvidia, as it aims to gain an edge in the competitive market that supports doctors and streamlines hospital billing and operations. Draped head-to-toe in black, on a day forecast to be in the 90s, Abridge CEO Shiv Rao announced that Eli Lilly would make a strategic investment in the company. Abridge also announced a new partnership with Nvidia to develop “the first foundation model purpose-built for clinical conversations,” according to a release. “Imagine you try to throw a generic AI model into healthcare.” Kimberly Powell, vice president and general manager of healthcare at Nvidia, said on stage during a keynote event. “It doesn’t understand the clinical language, it doesn’t have the clinical reasoning, and it surely doesn’t have the domain expertise of all of the long running tasks and interconnected work that has to happen for workflows to be completely transformed, and so if that is the case, that generic AI is just not going to work.”Continue to STAT+ to read the full story…